FOXF2

FOXF2 Full Name

forkhead box F2

FOXF2 Introduction

The FOXF2 transcription factor plays an indispensable role in mammalian morphogenesis, particularly within the respiratory and digestive systems. It functions as a key regulator of mesenchymal-epithelial interactions, guiding the proper branching morphogenesis of organs like the lungs and stomach. During embryonic development, FOXF2 expression is restricted to specific stromal and smooth muscle cell populations, where it orchestrates the proliferation and differentiation necessary for septation and organ enlargement. Loss-of-function studies in murine models demonstrate that FOXF2 deficiency disrupts the normal patterning of these tissues, leading to significant structural abnormalities and highlighting its non-redundant role in organogenesis.

Figure 1. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition.(Meyer-Schaller N, Heck C, Tiede S, et al. 2018)

Molecular Network and Signaling Pathways
At the molecular level, FOXF2 functions as a potent transcriptional activator or repressor, integrating into a complex web of intracellular signaling cascades. It directly influences the TGF-beta and WNT signaling pathways, which are critical for cell fate determination and tissue remodeling. By binding to the promoters of key downstream effectors, FOXF2 can alter the cellular response to external stimuli. Furthermore, it exhibits cooperative interactions with other transcription factors, including members of the ETS family, to synergistically control target gene expression. This positioning at the center of multiple pathways underscores its significance as a pivotal node for orchestrating coordinated cellular responses.

Pathological Implications and Oncological Interest
Recent research has increasingly implicated FOXF2 in human disease, most notably in the context of cancer progression and fibrosis. While it can act as a tumor suppressor in some malignancies by inhibiting epithelial-mesenchymal transition, it surprisingly promotes invasion and metastasis in other cancer types, such as breast and gastric cancers. This context-dependent duality makes it a challenging therapeutic target. Moreover, its dysregulation is observed in idiopathic pulmonary fibrosis, where aberrant expression contributes to pathological fibroblast activation. Consequently, FOXF2 is now viewed as a promising diagnostic and prognostic biomarker, warranting further investigation for potential targeted interventions.

Alternate Names for FOXF2

FOXF2; forkhead box F2; FKHL6; forkhead box protein F2; FREAC2; FKH L6; FKHL 6; FKHL6; Forkhead box F2; Forkhead box protein F2; Forkhead like 6; Forkhead related activator 2; Forkhead related protein FKHL6; Forkhead related transcription factor 2; FOX F2

View more

• 1.Meyer-Schaller N, Heck C, Tiede S, et al. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Breast Cancer Research, 2018, 20(1): 118.